PHYSICAL ORGANIZATION OF LIPIDS IN THE CELL-WALL OF MYCOBACTERIUM-CHELONAE

被引:145
|
作者
NIKAIDO, H [1 ]
KIM, SH [1 ]
ROSENBERG, EY [1 ]
机构
[1] UNIV CALIF BERKELEY,DEPT CHEM,BERKELEY,CA 94720
关键词
D O I
10.1111/j.1365-2958.1993.tb01647.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mycobacterial cell wall functions as an effective permeability barrier, making these bacteria resistant to most antibacterial agents. It has been assumed that this low permeability was due to the presence of a large amount of unusual lipids in the cell wall, but it was not known how these lipids are able to produce such an exceptional barrier. We report here the first experimental evidence on the physical arrangement of these lipids based on X-ray diffraction studies of purified Mycobacterium chelonae cell wall, a result suggesting that the hydrocarbon chains of the cell-wall lipids are arranged predominantly in a direction perpendicular to the cell wall surface, probably producing an asymmetric bilayer structure.
引用
收藏
页码:1025 / 1030
页数:6
相关论文
共 50 条
  • [1] FLUIDITY OF THE LIPID DOMAIN OF CELL-WALL FROM MYCOBACTERIUM-CHELONAE
    LIU, J
    ROSENBERG, EY
    NIKAIDO, H
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (24) : 11254 - 11258
  • [2] MYCOBACTERIUM-CHELONAE KERATITIS
    MATOBA, A
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1987, 103 (04) : 595 - 596
  • [3] MYCOBACTERIUM-CHELONAE KERATITIS
    RICHARDSON, P
    CRAWFORD, GJ
    SMITH, DW
    XANTHIS, CP
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF OPHTHALMOLOGY, 1989, 17 (02): : 195 - 196
  • [4] ENDOGENOUS MYCOBACTERIUM-CHELONAE ENDOPHTHALMITIS
    AMBLER, JS
    MEISLER, DM
    ZAKOY, ZN
    HALL, GS
    SPECH, TJ
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1989, 108 (03) : 338 - 339
  • [5] MYCOBACTERIUM-CHELONAE HIP INFECTION
    HEATHCOCK, R
    DAVE, J
    YATES, MD
    JOURNAL OF INFECTION, 1994, 28 (01) : 104 - 105
  • [6] IMMUNOMODULATORY PROPERTIES OF A STRAIN OF MYCOBACTERIUM-CHELONAE .2. QUALITATIVE AND QUANTITATIVE STIMULATION OF MOUSE SPLENOCYTES BY MYCOBACTERIUM-CHELONAE
    NEWAY, T
    BARRAT, F
    PERSON, JM
    BOULOUIS, HJ
    PILET, C
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 1990, 13 (02) : 85 - 94
  • [7] CIPROFLOXACIN THERAPY OF MYCOBACTERIUM-CHELONAE KERATITIS
    HWANG, DG
    BISWELL, R
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1993, 115 (01) : 114 - 115
  • [8] INTERPLAY OF CELL-WALL BARRIER AND BETA-LACTAMASE ACTIVITY DETERMINES HIGH-RESISTANCE TO BETA-LACTAM ANTIBIOTICS IN MYCOBACTERIUM-CHELONAE
    JARLIER, V
    GUTMANN, L
    NIKAIDO, H
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) : 1937 - 1939
  • [9] A PSEUDOEPIDEMIC OF MYCOBACTERIUM-CHELONAE - CONTAMINATION OF A BRONCHOSCOPE AND AUTOCLEANER
    CAMPAGNARO, RL
    TEICHTAHL, H
    DWYER, B
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1994, 24 (06): : 693 - 695
  • [10] COMBINATION-DRUG TESTING OF MYCOBACTERIUM-CHELONAE
    MATOBA, AY
    LEE, BL
    ROBINSON, NM
    PENLAND, R
    OSATO, MS
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (09) : 2786 - 2789